|
시장보고서
상품코드
2049246
근접치료 시장 : 서비스 유형별, 기술별, 조달 모드별, 최종사용자별, 지역별(2026-2034년)Brachytherapy Market Report by Service Type (History and Physical Report, Discharge Summary, Operative Note or Report, Consultation Report, and Others ), Technology, Mode of Procurement, End-User, and Region 2026-2034 |
||||||
세계의 근접치료 시장 규모는 2025년에 9억 1,960만 달러에 달했습니다. 향후에 대해 IMARC Group은 2034년까지 시장 규모가 12억 6,270만 달러에 달하며, 2026-2034년에 CAGR 3.48%로 성장할 것으로 예측하고 있습니다.
근접치료(Brachytherapy)는 체내 암 종양 근처 또는 그 직근에 내장된 방사선원에서 직접 방사선을 조사하는 방사선 치료의 일종입니다. 이 방사선원은 감마선을 발생시켜 암세포에 집중시킴으로써 주변 정상조직의 손상을 줄입니다. 근접치료(Brachytherapy)는 질병의 중증도 및 손상 정도에 따라 저선량률(LDR) 또는 고선량률(HDR)로 시행됩니다. LDR은 작은 방사성 시드를 종양내 또는 종양 주변에 영구적으로 이식하는 반면, HDR은 각 세션이 끝난 후 방사성 소스를 환자의 몸에서 꺼내어 고위험군 암 환자에게 사용됩니다.
각종 암 발병률의 증가는 세계 시장을 촉진하는 주요 요인 중 하나입니다. 소선원치료(Brachytherapy)는 자궁경부암, 피부암, 유방암에 매우 효과적인 치료법으로 입증되어 시장 성장에 크게 기여하고 있습니다. 또한 작은 종양에 정밀하고 매우 국소적으로 방사선을 조사할 수 있는 고품질 근접치료(Brachytherapy) 장비가 출시되면서 환자와 의료진 모두 이 치료법에 대한 수용도가 높아지고 있습니다. 종양 치료의 기술 발전과 노화성 황반변성(신생혈관형) 치료를 위한 임상 시험 등 광범위한 연구개발(R&D)도 시장 성장에 큰 탄력을 주고 있습니다. 이 외에도 전 세계 의료관광의 확대, 근접치료(Brachytherapy)의 장점과 비용 효율성, 수술이나 외부 방사선 치료(EBT)에 비해 치료율 향상에 대한 인식이 높아지면서 시장을 크게 견인하고 있습니다.
IMARC Group의 최신 보고서는 세계 근접치료(Brachytherapy) 시장에 대한 모든 중요한 측면을 다루고 심층 인사이트를 제공합니다. 내용은 시장의 거시적 개요, 업계 실적에 관한 미시적 상세, 최근 동향, 주요 시장 촉진요인 및 과제, SWOT 분석, 포터의 Five Forces 분석, 밸류체인 분석 등으로 구성되어 있습니다. 이 보고서는 업계 관계자, 투자자, 연구자, 컨설턴트, 비즈니스 전략가, 글로벌 근접치료(Brachytherapy) 시장에 관여하고 있거나 진출을 계획하고 있는 사람이라면 누구나 반드시 읽어야 할 자료입니다.
목차
제1장 서문
제2장 조사 범위와 조사 방법
제3장 개요
제4장 서론
제5장 세계의 근접치료 시장
제6장 시장 내역 : 서비스 유형별
제7장 시장 내역 : 기술별
제8장 시장 내역 : 조달 모드별
제9장 시장 내역 : 최종사용자별
제10장 시장 내역 : 지역별
제11장 SWOT 분석
제12장 밸류체인 분석
제13장 Porter's Five Forces 분석
제14장 경쟁 구도
KSAThe global brachytherapy market size reached USD 919.6 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,262.7 Million by 2034, exhibiting a growth rate (CAGR) of 3.48% during 2026-2034.
Brachytherapy, also known as internal radiation therapy, is a form of radiotherapy in which radiation is transported directly through a source implanted near or next to the cancerous tumor in the body. The source produces gamma rays that are focused on cancer cells and reduce the damage to surrounding healthy tissue. Brachytherapy is either administered in Low Dose Rate (LDR) or High Dose Rate (HDR) depending upon the severity of the disease and its damage. For LDR, small radioactive seeds are implanted permanently in or around the tumor, whereas, for HDR, radioactive sources are removed from the patient's body at the termination of each session and is used in the cases of high-risk cancers.
The rising prevalence of different types of cancer is one of the key factors driving the global market. Brachytherapy has been proven to be an extremely effective treatment option for cervical, skin and breast cancers, which is contributing significantly to its market growth. Furthermore, the availability of high-quality brachytherapy equipment that provides accurate and extremely localized doses of radiation to small tumors has enhanced the acceptance of the therapy amongst patients and medical professionals alike. Technological advancements in oncology treatments and extensive research and development (R&D), such as trials for treating neovascular age-related macular degeneration, have also provided a significant boost to the market growth. In addition to this, growing medical tourism across the globe, along with increasing awareness about the advantages of brachytherapy and its cost-effectiveness and increasing cure rate as compared to surgery or external beam therapy (EBT), is also significantly driving the market.
IMARC Group's latest report provides a deep insight into the global brachytherapy market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. This report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the global brachytherapy market in any manner.
KEY MARKET SEGMENTATION :
Breakup by Service Type:
- History and Physical Report
- Discharge Summary
- Operative Note or Report
- Consultation Report
- Others (Pathology Report, Radiology Report, etc.)
Breakup by Technology:
- EMR/EHR
- PACS
- RIS
- SRT
- Others
Breakup by Mode of Procurement:
- Outsourcing
- Offshoring
- Both
Breakup by End-User:
- Hospitals
- Clinics
- Clinical Laboratories
- Academic Medical Centers
- Others
Breakup by Region:
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
COMPETITIVE LANDSCAPE:
The report has also analyzed the competitive landscape of the market with some of the key players being Acusis Software India Pvt Ltd., Transcend Services, Inc., Naunce Communications, Inc., MModal Global Services Pvt. Ltd., iMedX Information Services Pvt. Ltd., Global Medical Transcription LLC, nThrive Solutions LLC, MTBC (CareCloud, Inc.), Medi-Script Plus and Transtech Medical Solutions LLC.
Key Questions Answered in This Report
1. What was the size of the global brachytherapy market in 2025?
2. What is the expected growth rate of the global brachytherapy market during 2026-2034?
3. What are the key factors driving the global brachytherapy market?
4. What has been the impact of COVID-19 on the global brachytherapy market?
5. What is the breakup of the global brachytherapy market based on the end user?
6. What are the key regions in the global brachytherapy market?
7. Who are the key players/companies in the global brachytherapy market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Brachytherapy Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Breakup by Service Type
- 5.5 Market Breakup by Technology
- 5.6 Market Breakup by Mode of Procurement
- 5.7 Market Breakup by End User
- 5.8 Market Breakup by Region
- 5.9 Market Forecast
6 Market Breakup by Service Type
- 6.1 History and Physical Report
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Discharge Summary
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Operative Note or Report
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Consultation Report
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Others
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
7 Market Breakup by Technology
- 7.1 EMR/EHR
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 PACS
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 RIS
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 SRT
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
8 Market Breakup by Mode of Procurement
- 8.1 Outsourcing
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Offshoring
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Both
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by End User
- 9.1 Hospitals
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Clinics
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Clinical Laboratories
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 9.4 Academic Medical Centers
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
- 9.5 Others
- 9.5.1 Market Trends
- 9.5.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
- 10.2 Europe
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
- 10.3 Asia Pacific
- 10.3.1 Market Trends
- 10.3.2 Market Forecast
- 10.4 Middle East and Africa
- 10.4.1 Market Trends
- 10.4.2 Market Forecast
- 10.5 Latin America
- 10.5.1 Market Trends
- 10.5.2 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Acusis Software India Pvt Ltd.
- 14.3.2 Transcend Services, Inc.
- 14.3.3 Naunce Communications, Inc.
- 14.3.4 MModal Global Services Pvt. Ltd.
- 14.3.5 iMedX Information Services Pvt. Ltd.
- 14.3.6 Global Medical Transcription LLC
- 14.3.7 nThrive Solutions LLC
- 14.3.8 MTBC (CareCloud, Inc.)
- 14.3.9 Medi-Script Plus
- 14.3.10 Transtech Medical Solutions LLC
